VALITOR

Valitor's technology enables us to engineer BioBetter products with previously unattainable pharmacological properties to maximize clinical impact... Our core technology platform originated at UC Berkeley and enables us to generate multivalent protein (MVP) conjugates by tethering multiple copies of bioactive molecules (e.g., camelid antibodies, cytokines, etc.) to single-chain, soluble biopolymers.

Also known as: Valitor, Inc

Primary location: Berkeley United States